HCA Healthcare, Inc. - Form 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report on Form 10-Q for HCA Inc. (HCA), a holding company owning and operating hospitals and related health care entities. The report covers the quarterly and nine-month periods ended September 30, 2002. As of this date, HCA affiliates operated 175 hospitals and 74 freestanding surgery centers across 22 U.S. states, England, and Switzerland.
Key Financial Metrics
| Metric (in millions) | Quarter Ended Sep 30, 2002 | Quarter Ended Sep 30, 2001 | 9 Months Ended Sep 30, 2002 | 9 Months Ended Sep 30, 2001 |
|---|---|---|---|---|
| Revenues | $4,929 | $4,438 | $14,705 | $13,415 |
| Reported Net Income | $200 | $256 | $935 | $845 |
| Adjusted Net Income | $200 | $273 | $935 | $897 |
| Diluted EPS (Reported) | $0.38 | $0.48 | $1.78 | $1.56 |
| Operating Cash Flow (9 Months) | $1,964 | $821 | ||
| Total Debt (Long-term + Current) | $7,360 | $7,360 | ||
| Cash and Equivalents | $138 | $85 | ||
Note: Debt figures represent Long-term debt ($6,933M) plus Long-term debt due within one year ($427M) as of Sep 30, 2002.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 11.1% for the quarter and 9.6% for the nine months compared to the prior year. This was driven by a 3.2% increase in equivalent admissions and a 7.6% increase in revenue per equivalent admission, largely due to favorable managed care contract renewals.
- Profitability Decline (Quarterly): Reported net income for the quarter decreased 21.7% to $200 million. This decline was primarily due to a $168 million impairment charge on investment securities (equity securities held by the insurance subsidiary) and the absence of a $112 million gain on facility sales recorded in the prior year.
- Profitability Growth (Nine Months): Reported net income for the nine months increased 10.7% to $935 million, driven by revenue growth and a 120 basis point reduction in other operating expenses as a percentage of revenue.
- Expense Trends: Salaries and benefits remained stable as a percentage of revenue (40.6% vs 40.7%). The provision for doubtful accounts increased to 8.3% of revenue due to higher bad debts from self-pay and uninsured patients.
Guidance, Outlook, Risks, and Unusual Items
- Unusual Items:
- Investment Impairment: A $168 million non-cash charge was recorded in Q3 2002 for "other-than-temporary" declines in the fair value of equity securities held by the insurance subsidiary.
- Facility Sales: The prior year quarter included a $112 million gain on the sale of facilities, which did not recur in 2002.
- Goodwill Accounting: HCA adopted SFAS 142 on Jan 1, 2002, ceasing goodwill amortization. This reduced depreciation and amortization expenses compared to the prior year.
- Legal and Regulatory Risks:
- HCA remains subject to ongoing federal and state investigations regarding business practices, including qui tam actions and shareholder derivative suits.
- A $250 million settlement with the Centers for Medicare and Medicaid Services (CMS) regarding cost reports was announced in March 2002 but remains subject to DOJ approval and a definitive agreement. No liability was accrued as of Sep 30, 2002, due to uncertainty.
- Management anticipates continued investigative activity and potential substantial fines or penalties if violations are found.
- Capital Allocation:
- HCA announced an agreement in principle to acquire the 14-hospital Health Midwest system for $1.125 billion, with a commitment to $450 million in capital expenditures in the Kansas City market over five years.
- Stock repurchases continued, with 6.2 million shares purchased for $282 million in Q3 2002 under a new authorization.
Investor Verification Checklist
- CMS Settlement Status: Verify the final status of the $250 million CMS understanding and whether a definitive agreement has been executed or approved by the DOJ.
- Investment Portfolio Health: Review the composition of the insurance subsidiary's equity portfolio to assess the risk of further "other-than-temporary" impairment charges.
- Legal Contingencies: Monitor developments in the consolidated qui tam actions and shareholder derivative suits (e.g., Morse and McCall cases) for potential material liabilities.
- Health Midwest Acquisition: Confirm the closing of the Health Midwest acquisition and the integration timeline.
- Bad Debt Trends: Analyze the trend in the provision for doubtful accounts, specifically regarding self-pay and uninsured patient volumes.